Obonoruma Ekhaese, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10907 Memorial Hermann Dr Ste 440, Pearland, TX 77584 Phone: 832-915-8140 |
Dr. Antonio Nathan Villamor Iii, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 10970 Shadow Creek Pkwy Ste 280, Pearland, TX 77584 Phone: 713-436-7500 Fax: 713-436-7505 |
Jack Joseph Blumenthal, D.O. Surgery Medicare: Not Enrolled in Medicare Practice Location: 2550 Thelma St, Pearland, TX 77581 Phone: 281-485-3361 Fax: 281-485-3361 |
Dr. Jennifer Burris, Surgery Medicare: Accepting Medicare Assignments Practice Location: 2401 Fastwater Creek Ct, Pearland, TX 77584 Phone: 832-260-2603 |
News Archive
An analysis of a decade-long tuberculosis (TB) programme in China has revealed that prevalence rates of the disease have fallen substantially since the introduction of the TB control strategy known as 'DOTS' to half of the country's population.
The recent U.S. Food and Drug Administration (FDA) approval of a brain aneurysm device has opened the door for neurosurgeons at Jefferson Hospital for Neuroscience (JHN) to offer advanced treatment to patients suffering from large or giant aneurysms who otherwise have limited, effective options.
ZONARE Medical Systems, Inc., a developer of high-end ultrasound solutions, today announced a new software release for its z.one ultrasound platform here at the 96th Annual Meeting of the Radiological Society of North America (RSNA), Nov. 28 – Dec. 3, 2010. Designed to continually improve image quality and system performance, the 11th software release in six years also includes new advanced software applications and transducers which further expands the clinical utility of the z.one system in radiology, obstetric and vascular imaging.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.
› Verified 5 days ago